pentagastrin and yf 476

pentagastrin has been researched along with yf 476 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akuzawa, S; Batt, AR; Kendrick, DA; Miyata, K; Nishida, A; Ohta, M; Rooker, DP; Ryder, H; Satoh, M; Semple, G; Szelke, M1
Akuzawa, S; Miyata, K; Nishida, A; Ohta, M; Satoh, M; Semple, G; Takemoto, Y; Takinami, Y; Uchida, A; Yuki, H1
Akuzawa, S; Ito, H; Kobayashi-Uchida, A; Miyata, K; Nishida, A; Ohta, M; Satoh, M; Semple, G; Takemoto, Y; Takinami, Y; Yuki, H1
Black, J; Boyce, M; Warrington, S1

Trials

1 trial(s) available for pentagastrin and yf 476

ArticleYear
Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects.
    British journal of clinical pharmacology, 2013, Volume: 76, Issue:5

    Topics: Administration, Oral; Adult; Benzodiazepinones; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Female; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Pentagastrin; Phenylurea Compounds; Receptor, Cholecystokinin B; Single-Blind Method; Young Adult

2013

Other Studies

3 other study(ies) available for pentagastrin and yf 476

ArticleYear
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Journal of medicinal chemistry, 1997, Jan-31, Volume: 40, Issue:3

    Topics: Administration, Oral; Animals; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Brain; Devazepide; Dogs; Gastric Acid; Hormone Antagonists; Molecular Structure; Pancreas; Pentagastrin; Phenylurea Compounds; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship

1997
YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:1

    Topics: 3T3 Cells; Animals; Benzodiazepinones; Brain; COS Cells; Dogs; Gastric Acid; Gastric Mucosa; Hormone Antagonists; Humans; Male; Mice; Pancreas; Pentagastrin; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Stereoisomerism

1997
Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.
    Arzneimittel-Forschung, 1998, Volume: 48, Issue:4

    Topics: Animals; Benzodiazepinones; Dogs; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Hormone Antagonists; Male; Pentagastrin; Peptones; Phenylurea Compounds; Receptors, Cholecystokinin

1998